1. A method for the detection of a compound that mimics, potentiates or inhibits the physiological effect of the ob-protein, which method comprises:
(a) for a compound which mimics the physiological effect of the ob-protein, assessing the effect of the compound upon an ob-protein activated signal transducer and activator of transcription (STAT) DNA response element coupled to a reporter gene; or
(b) for a compound which potentiates or inhibits the physiological effect of the ob-protein, assessing the effect of the compound upon the response provided by ob protein upon an ob-protein activated STAT DNA response element coupled to a reporter gene:
wherein, the response element and the reporter are expressed in an ob-protein responsive cell line or ob-protein responsive cells, which cell line is an endothelium derived cell line and which cells are endothelium derived cells.
2. A method according to claim 1, wherein the endothelium-derived cell line is a human immortalised endothelial cell line, a murine or other non-human immortalised endothelial cell line.
3. A method according to claim 1 or claim 2, wherein the human endothelium derived cell line is an ECV304-human umbilical cord cell line.
4. A method according to any one of claims 1 to 3, wherein the murine endothelial cell line is selected from the list consisting of:
SVEC4-10endothelial lymph node cells, SV40 transformed;
SVEC4-10EE2endothelial lymph node cells, SV46 transformed;
SVEC-10EHR1endothelial lymph node cells, SV40 transformed;
IP-1Bendothelial lymph node cells, SV40 transformed;
2F-2Bendothelial lymph node cells, SV40 transformed;
3B-11endothelial lymph node cells, SV40 transformed;
2H-11endothelial lymph node cells, SV40 transformed; and
MS1 (mile SVEN 1)endothelial pancreatic islet cells, SV40 transformed.
5. A method according to claim 1, wherein the endothelium-derived cells are human primary endothelial cells, or murine or other non-human primary endothelial cells.
6. A method according to claim 1, wherein the endothelium-derived cells are selected from the list consisting of:
HUVEChuman umbilical vein endothelial cells;
HUAEChuman umbilical artery endothelial cells;
HAEChuman aortic endothelial cells;
HPAEChuman pulmonary artery endothelial cells;
HDMECahuman microvascular endothelial cells, adult dermis; and
HDMECnhuman microvascular endothelial cells, neonatal dermis.
7. A method according to claim 1, wherein the polypeptide capable of stimulating an ob-protein activated STAT DNA response element is a functional isoform of the leptin receptor
8. A method according to claim 1, wherein the response element is coupled to a promoter gene, preferably a minimal promoter.
9. A method according to claim 1, wherein the response element is a nucleotide of formula TT(N)n AA, where N is any nucleotide and n is 4, 5 or 6.
10. A method according to claim 9, wherein the response element is TTCCCGGAA.
11. A method according to claim 9, wherein the response element is selected from: ATTTCCCCGAAAT, ATTTCCCGTAAAT, ACTTCTTGGAATT and ACTTCTAGGAATT.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. An alkenyl-group-containing isobutylene group block copolymer comprising a polymer block derived from (a) a monomer component containing isobutylene group as a predominant monomer and (b) a monomer component not containing isobutylene group as a predominant monomer and copolymer containing an alkenyl group of the following general formula (1);
12
wherein the plurality of R1 may be the same or different and each represents hydrogen, halogen, or a substituted or unsubstituted monovalent organic group:
2. The alkenyl-group-containing isobutylene group block copolymer according to claim 1 wherein said polymer block derived from (b) monomers component not containing isobutylene group as a predominant monomer contains said alkenyl group of general formula (1).
3. The alkenyl-group-containing isobutylene group block copolymer according to claim 1 or 2 wherein said copolymer has at least one terminal alkenyl group.
4. The alkenyl-group-containing isobutylene group block copolymer according to claim 1, 2, or 3 wherein the alkenyl group is allyl.
5. The alkenyl-group-containing isobutylene group block copolymer according to claim 1, 2, 3, or 4 wherein said polymer block derived from (b) a monomer component not containing isobutylene group as a predominant monomer is a polymer block derived from a monomer component containing as a predominant monomer an aromatic vinyl monomer.
6. The alkenyl-group-containing isobutylene group block copolymer according to claim 5 which is a triblock copolymer comprising a polymer block derived from a monomer component containing as a predominant monomer an aromatic vinyl monomer componenta polymer block derived from (a) a monomercomponent containing isobutylene group as a predominant monomer a polymer block derived from a monomer component containing as a predominant monomer an aromatic vinyl monomer component.
7. A process for producing an alkenyl-group-containing isobutylene group block copolymer in which an alkenyl-group-containing silicon compound is added in the course of the polymerization of (a) a monomer component containing isobutylene group as a predominant monomer and (b) a monomer component not containing isobutylene group as a predominant monomer in the presence of a polymerization initiator of the following general formula (2);
13
wherein the plurality of R2 may be the same or different and each represents hydrogen or a monovalent hydrocarbon group containing 1 to 6 carbon atoms; R3 represents a mono- or poly-valent aromatic hydrocarbon group or a mono- or poly-valent aliphatic hydrocarbon group; X represents halogen, or an alkoxy or acyloxy group containing 1 to 6 carbon atoms; and n represents an integer of 1 to 6, with providing that n is equal to 2 or more, the plurality of X may be the same or different.
8. The process according to claim 7 wherein the alkenyl-group-containing silicon compound is added when the polymerization of (a) a monomer component containing isobutylene group as a predominant monomer and (b) a monomer component not containing isobutylene group as a predominant monomer has substantially completed.
9. The process according to claim 7 or 8 wherein the alkenyl-group-containing silicon compound is a compound of the following general formula (3);
14
wherein the pluralities of R4 and R5 may respectively be the same or different and each represents hydrogen, halogen, or a substituted or unsubstituted monovalent organic group.
10. The process according to claim 9 wherein the alkenyl-group-containing silicon compound is allyltrimethylsilane.
11. The process according to claim 7, 8, 9, or 10 wherein the polymerization initiator is 1,4-bis(1-chloro-1-methylethyl)benzene.
12. The process according to claim 7, 8, 9, 10 or 11 wherein (b) a monomer component not containing isobutylene group as a predominant monomer is a monomer component containing as a predominant monomer an aromatic vinyl monomer component.
13. The process according to claim 12 wherein the aromatic vinyl monomer component is at least one member selected from the group consisting of styrene, -methylstyrene, p-methylstyrene, vinylnaphthalene derivatives, and indene derivatives.
14. An alkenyl-group-containing isobutylene group block copolymer as produced by the process according to claim 7, 8, 9, 10, 11, 12 or 13.
15. A reactive-silicon-group-containing isobutylene group block copolymer comprising a polymer block derived from (a) a monomer component containing isobutylene group as a predominant monomer and a polymer block derived from (b) a monomer component not containing isobutylene group as a predominant monomer, and said copolymer containing a reactive silicon group of general formula (4);
15
wherein a plurality of R6 may be the same or different and each represents hydrogen, halogen, or a substituted or unsubstituted monovalent organic group; R7 represents a monovalent organic group of 1 to 5 carbon atoms, and when two of R7are contained, these may be the same or different; Y represents a halogen atom or alkoxy group, and when more than two of Y are contained, these may be the same or different; and a represents an integer of 0 to 2.
16. A process for producing a reactive-silicon- group-containing isobutylene group block copolymer which comprises subjecting the compound of the following general formula (5) to hydrosilylation reaction with an alkenyl group of an alkenyl-group-containing isobutylene group block copolymer comprising a polymer block derived from (a) a monomer component containing isobutylene group as a predominant monomer and a polymer block derived from (b) a monomer component not containing isobutylene group as a predominant monomer;
16
wherein R7 represents a monovalent organic group of 1 to 5 carbon atoms, and when two of R7 are contained, these may be the same or different; Y represents a halogen atom or alkoxy group, and when more than two of Y are contained, these may be the same or different; and a represents an integer of 0 to 2.
17. The process according to claim 16 wherein the alkenyl-group-containing isobutylene group block copolymer is the alkenyl-group-containing isobutylene group block copolymer according to claim 1.
18. The process according to claim 16 or 17 wherein alkenyl-group-containing isobutylene group block copolymer is produced by the process according to claim 7, 8, 9, 10, 11, 12, or 13.
19. The process according to claim 16, 17, or 18 wherein hydrosilylation reaction is carried out using a plutinum complex as a catalyst at the temperature of 40 C.